✦ LIBER ✦
Assessing the clinical benefit of nuclear matrix protein 22 in the surveillance of patients with nonmuscle-invasive bladder cancer and negative cytology : A decision-curve analysis
✍ Scribed by Shahrokh F. Shariat; Caroline Savage; Thomas F. Chromecki; Maxine Sun; Douglas S. Scherr; Richard K. Lee; Giovanni Lughezzani; Mesut Remzi; Michael J. Marberger; Pierre I. Karakiewicz; Andrew J. Vickers
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 170 KB
- Volume
- 117
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.